Offerings
Uses
The Race
About Us
Resources
Create a CKB Account
Create a mastermind account

Clinical Diagnostics

Accelerate NGS variant interpretation with rapid search and insight into the full text of the genomic literature

Clinical Uses

Precision Therapeutics

Partner with us to gain a comprehensive view of the genetics of your disease of interest, from discovery to commercialization

Pharma Uses

Software Solutions

Explore our platforms for germline and somatic variant interpretation


Access article information on more than 26 million variants, as well as curated germline variant content.

Meet Mastermind

Our Cancer Knowledgebase is used to interpret cancer variants, connecting them to therapies and clinical trials


Meet CKB

Services

Partner with our team of experts to create Tailored Solutions for your unique needs

Clinical Diagnostic Services
Precision Therapeutics Services

Data

Gain access to an expansive, constantly updated database of curated genomic information

Learn More
Offerings
Software
Clinical Diagnostics Services
Precision Therapeutics Services
Data
Somatic Knowledgebase
Uses
The Race
About Us
Resources
schedule a discovery call

Newsroom


The latest featured press and company announcements from Genomenon.

For general press inquiries, please contact Colleen McMillen, VP of Marketing: cmcmillen@genomenon.com

2,000
Clinical Labs rely on Mastermind
50%
of the clinical exome has been curated by Genomenon
100+
Grad-level Scientists power Genomenon’s genomic intelligence development
145+
Countries around the world have labs powered by Mastermind
NewsAnnouncementsEvents

News

Read the latest coverage featuring Genomenon.

Nov 12, 2024
The Variant Interpretation Bottleneck in Genomics for Oncology Clinical Research is Opening, say Illumina, Genomenon
Read More >
Nov 7, 2024
GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting
Read More >
Nov 7, 2024
GenomOncology Inks Deal to Offer Access to Genomenon Genomic Data
Read More >
Oct 17, 2024
Michigan Venture Capital Association Entrepreneurial Investment Successes
Read More >
Oct 4, 2024
Genomenon Mastermind ACMG Secondary Findings Variants Update
Read More >
Sep 23, 2024
High-Growth Companies Honored Fasttrack Awards 2024
Read More >
May 16, 2024
Genomenon Combines AI Scientist Curation Gene-Disease Insights
Read More >
May 9, 2024
Genomenon Acquired Variant Database, Team Jackson Laboratory
Read More >
May 2, 2024
Genomenon Partners Pharming Improve Diagnosis Rare Immunodeficiency Syndrome
Read More >
Mar 29, 2024
An Established Relationship: How semi-automated biomedical evidence curation could open up genetic diagnostics
Read More >
Mar 15, 2024
Genomenon Combines AI with Scientist Curation to Offer Gene-Disease Insights
Read More >
Jan 3, 2024
Trendspotting: What’s Coming for Diagnostics in 2024
Read More >
Jan 3, 2024
Trendspotting: What’s Coming Biotech 2024
Read More >
Jan 3, 2024
Trendspotting: What’s Coming Clinical Trials Research 2024
Read More >
Jan 3, 2024
Trendspotting: What’s Coming Diagnostics 2024
Read More >
Dec 11, 2023
Current Advances Future Directions Rare Disease Diagnosis
Read More >
Dec 6, 2023
Genomenon Curate-Pro, Interpret
Read More >
Dec 5, 2023
Curation On-Demand Service for Genetic Testing Labs Debuts
Read More >
Nov 2, 2023
Genomenon Delivers Fully Curated Clinical Exome Mastermind 3 Release ASHG
Read More >
Aug 10, 2023
When Your Data Too Much Process, Turn AI/ML
Read More >
Jul 20, 2023
AI Company Aims Curate Entire Human
Read More >
Jul 11, 2023
Genomenon Acquires Boston Genetics Rapid Human Genome Curation
Read More >
Jun 30, 2023
Genomenon Accelerates Quest Curate Entire Human Genome Boston Genetics Acquisition
Read More >
Jun 29, 2023
Genomenon Acquires Boston Genetics Accelerate Curation of Human Genome
Read More >
Jun 28, 2023
Genomenon Ann Arbor Acquires Boston Genetics Speed Curation Human Genome
Read More >
Jun 27, 2023
Genomenon Acquires Boston Genetics Accelerate Curation Human Genome
Read More >
Jun 27, 2023
Genomics AI Firm Genomenon Acquires Boston Genetics
Read More >
Jun 27, 2023
Genomics AI Genomenon Acquires Boston Genetics
Read More >
Feb 7, 2023
Genomenon, Flagship Biosciences Partner Biomarker Discovery, Companion Dx Development
Read More >
Feb 6, 2023
Flagship Biosciences Genomenon Partner Advance Precision Medicine Development
Read More >
Jan 9, 2023
Genomenon Named Top Ann Arbor Tech Company 2023
Read More >
Dec 5, 2022
Partnership Hopes Advance Precision Drug Development
Read More >
Dec 2, 2022
Rare Disease Revolution
Read More >
Nov 30, 2022
Genomenon Inks AI/Genomics Deal Three Rare Neuro-Disease Orgs
Read More >
Nov 30, 2022
Genomenon, Nonprofits Team Up Genomic Data Rare Diseases
Read More >
Nov 29, 2022
Genomenon Collaborates Rare Disease Foundations Drug Development
Read More >
Nov 29, 2022
Genomenon Partners Neurodevelopmental Disease Groups Drug Development
Read More >
Nov 1, 2022
Genomenon publishes ENPP1 deficiency database
Read More >
Oct 31, 2022
Novel Solution Increases Diagnostic Yield, Accelerates Rare Disease Diagnoses
Read More >
Sep 27, 2022
Increasing Biologics Manufacturing Efficiency Lowering Costs QbD
Read More >
Sep 7, 2022
Genomenon Mastermind ClinVar
Read More >
Sep 6, 2022
Genomenon Integrates NIH Variant Data Mastermind
Read More >
Aug 25, 2022
BeginNGS Program Pediatric Rare Disease Dx, Treatment Rapid NGS, Data Curation
Read More >
Aug 24, 2022
Novel newborn screening whole genome sequencing acute management guidance screen diagnosis genetic diseases
Read More >
Aug 2, 2022
Genomenon Curate Genes Rady Children's BeginNGS Newborn Screening Panel
Read More >
Jul 26, 2022
Study potential genome treatment guide physicians genetic diseases
Read More >
Jul 26, 2022
Automated Genome Treatment System Help Manage Genetic Disease
Read More >
Jul 25, 2022
New consortium leverages infant screening accelerate treatment
Read More >
Jun 14, 2022
Rady Children’s Evaluate Scalability Rapid WGS 400 Known Genetic Diseases
Read More >
Jun 14, 2022
Rady Children’s Institute launches newborn genetic disease screening
Read More >
Jun 8, 2022
New Partnership Aims Improve Genomic Variant Interpretation
Read More >
Jun 7, 2022
Agilent Integrate Genomenon Search Engine, Accelerate Workflows Nvidia
Read More >
Jun 6, 2022
Curation Entire Human Genome Requires Human Artificial Intelligence
Read More >
Mar 12, 2022
Genomenon Wins Best Show Bio-IT World Conference & Expo 2022
Read More >
Mar 10, 2022
Ann Arbor Software Firm Genomenon $20 Million Funding Round
Read More >
Feb 28, 2022
Ultimate Vision Rare Disease
Read More >
Feb 24, 2022
Genomenon Forges Rare-Disease Partnership Advocacy Group
Read More >
Feb 23, 2022
Genomenon Partners Don’t Forget Morgan Provide Hope Rare Disease
Read More >
Feb 22, 2022
Genomenon Partners Rare-Disease Charity Variant Identification
Read More >
Feb 16, 2022
Human Genome Requires Interpretation. AI Can Make Happen
Read More >
Feb 15, 2022
Genomenon Wins NIH SBIR Grant Accelerate Variant Interpretation
Read More >
Feb 15, 2022
Genomenon Scores SBIR Grant Curate Genetic Drivers Disease
Read More >
Jan 31, 2022
Mike Klein Genomenon’s Technology Impact Overall Wellness
Read More >
Jan 5, 2022
Genomenon OmniTier Partner Mastermind’s Evidence Sources CompStor Insight
Read More >
Jan 5, 2022
Genomenon, OmniTier Integrate Genome Analysis Technologies
Read More >
Genomenon Delivers Fully Curated Clinical Exome Mastermind 3 Release ASHG
November 2, 2023
When Your Data Too Much Process, Turn AI/ML
August 10, 2023
AI Company Aims Curate Entire Human
July 20, 2023
Genomenon Acquires Boston Genetics Rapid Human Genome Curation
July 11, 2023
Genomenon Accelerates Quest Curate Entire Human Genome Boston Genetics Acquisition
June 30, 2023
Genomenon Acquires Boston Genetics Accelerate Curation of Human Genome
June 29, 2023

Announcements

Recent
2024
2023
2022
2021
2020
2019
2018 - 2016
November 7, 2024
GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting
November 6, 2024
SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research
October 31, 2024
Genomenon Strengthens Cancer Knowledgebase with Expansion of European Clinical Trial Data
October 3, 2024
Genomenon Targets WGS Analysis Costs with Curated ACMG Secondary Findings
July 11, 2024
Genomenon Launches Genetic Disease Sponsorship to Boost Rare Disease Diagnosis
November 7, 2024
GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting
November 6, 2024
SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research
October 31, 2024
Genomenon Strengthens Cancer Knowledgebase with Expansion of European Clinical Trial Data
October 3, 2024
Genomenon Targets WGS Analysis Costs with Curated ACMG Secondary Findings
July 11, 2024
Genomenon Launches Genetic Disease Sponsorship to Boost Rare Disease Diagnosis
June 20, 2024
Genomenon Achieves Critical Milestone with Half of Clinical Exome Curated
May 8, 2024
Genomenon Acquires The Jackson Laboratory’s CKB to Fuel its Mission to Curate the Human Genome
May 2, 2024
Genomenon Partners with Pharming to Advance APDS Diagnosis
March 14, 2024
Genomenon Presents Study Identifying 11,000 Gene Disease Relationships Across the Clinical Exome
February 21, 2024
Genomenon to Detail Gene Curation Across the Clinical Exome in Scientific Presentation at 2024 ACMG Annual Clinical Genetics Meeting
January 4, 2024
Genomenon Announces Participation in BIO Partnering
December 5, 2023
Genomenon Launches Curation On-Demand Service For Genetic Testing Labs
November 2, 2023
Genomenon Takes a Leap in the Race to Curate the Genome
October 24, 2023
Genomenon Names New Commercial Leadership to Support Growth in Clinical Diagnostic and Pharmaceutical Markets
June 27, 2023
Genomenon Acquires Boston Genetics to Accelerate Curation of Human Genome
May 30, 2023
Genomenon Wins Best of Show Award at Bio-IT World 2023 Conference and Expo
May 8, 2023
Genomenon Recognized by Frost & Sullivan for Genomic Intelligence Solutions and Software for Pharma and Clinical Diagnostics Companies
February 7, 2023
Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development
January 10, 2023
Genomenon Recognized as Top Tech Company to Watch in 2023 by Purpose Jobs
January 5, 2023
Genomenon to Participate in BIO Partnering at JPM During J.P. Morgan Week 2023
December 15, 2022
New Study Shows Comprehensive Genomic Evidence is Critical for Calculating Rare Disease Prevalence
November 29, 2022
Genomenon Partners with Three Rare Disease Foundations to Advance Precision Drug Development
November 15, 2022
Genomenon Provides Genomic Data on 450 Diseases to Advance Early Identification of Rare Disease in Newborns
October 31, 2022
New Study Presents Novel Solution to Increasing Diagnostic Yield and Accelerating Diagnosis of Rare Disease
September 7, 2022
Genomenon Integrates ClinVar Data into Mastermind to Support Clinical Decision-Making
August 2, 2022
Genomenon Partners with Rady Children’s Institute for Genomic Medicine on Newborn Screening by Next Generation Sequencing
June 7, 2022
Genomenon and Agilent Partner to Improve Genomic Variant Interpretation
May 12, 2022
Genomenon Wins Best of Show at Bio-IT World Conference & Expo 2022
May 10, 2022
Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data
February 22, 2022
Genomenon Partners with Don’t Forget Morgan to Provide New Hope for Rare Disease
February 15, 2022
Genomenon Awarded NIH Grant to Curate the Human Genome
January 4, 2022
Genomenon and OmniTier Partner to Bring Mastermind’s Evidence Sources to CompStor Insight
November 20, 2021
Genomenon Extends Insight into Genomic Evidence with Mastermind Search Companion
November 11, 2021
Genomenon and Inozyme Pharma Announce Partnership to Advance Genetic Diagnosis for Rare Disease Patients
November 4, 2021
Genomenon and Deep 6 AI Sign Proof of Concept Agreement to Increase Clinical Trial Matching Capabilities
September 20, 2021
Genomenon Announces Collaboration to Accelerate Genetic Diagnosis for Rare Disease Patients
August 26, 2021
Genomenon Hosts Clinical Genomics Experts at European Human Genetics Conference
June 1, 2021
Genomenon and Nostos Genomics Partner to Accelerate Rare Genetic Disease Diagnoses
May 20, 2021
Genomenon Publishes Key Findings from the Genomic Landscape for ALS
April 12, 2021
Genomenon and Limbus Partner to Advance Genomic Variant Interpretation
March 16, 2021
Genomenon Completes $5.3M Financing Round
January 26, 2021
Genomenon Announces Publication of Scientific Paper in Frontiers in Genetics
December 8, 2020
Genomenon Recognized as Top Precision Medicine Solution Provider
November 17, 2020
DNASTAR Integrates Genomenon Mastermind Database for Human Variant Analysis
October 13, 2020
Genomenon Releases Copy Number Variation (CNV) Search to Enhance Genomic Interpretation
October 7, 2020
Genomenon and Rady Children’s Institute for Genomic Medicine Collaborate to Accelerate Diagnosis of Rare Genetic Disorders in Newborns
August 11, 2020
Genomenon’s Klein Named Top 25 Biotechnology CEOs of 2020 TechCEOs
June 10, 2020
Genomenon Releases Novel Solution for Accelerated Genomic Diagnosis
May 12, 2020
Genomenon Partners with enGenome to Improve Variant Interpretation Accuracy and Speed
April 28, 2020
Genomenon’s Mastermind Now Finds Therapies Associated with Genetic Drivers
March 23, 2020
UCSC Genome Browser Integration of Mastermind Accelerates Genomic Variant Interpretation
February 26, 2020
Genomenon Releases Genomic Landscape for Ectodermal Dysplasias for Rare Disease Week
February 11, 2020
Genomenon Awarded Company of the Year in Genomics by Frost & Sullivan
January 20, 2020
Genomenon’s Mastermind Continues to Outpace Qiagen’s HGMD Genetic Database
January 7, 2020
Genomenon CEO to Present at 2020 Digital Medicine & Medtech Showcase
November 6, 2019
Genomenon Accelerates Rare and Genetic Disease Research with Mastermind Version 2.0
October 15, 2019
Genomenon’s Mastermind to be Integrated into SOPHiA Platform and Alamut Suite
October 2, 2019
Congenica Partners with Genomenon to Integrate Mastermind into Congenica Clinical Platform
October 2, 2019
Congenica Integrates Powerful New Curated Data
September 17, 2019
Genomenon Partners with BPAN Warriors to Find a Cure for Ultra-Rare Disease
August 20, 2019
Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market
August 6, 2019
Genomenon Wins NIH Grant to Develop Micropublications for Genomic Interpretation
July 9, 2019
Genomenon Granted Patent on Genomic Search Engine
June 6, 2019
Fusion Genes Found to be an Emerging Target in Cancer Diagnostics and Drug Development
May 14, 2019
Genomenon Kicks off Genomics Educators Program with Keck Graduate Institute
April 24, 2019
EY Announces Mike Klein of Genomenon Entrepreneur Of The Year 2019 Award Finalist
April 22, 2019
Genomenon Wins Best of Show at Bio-IT 2019
April 16, 2019
Genomenon Partners with Google to Make Genomic Data Available on Google Cloud Platform
April 2, 2019
LifeMap Sciences and Genomenon Partner to Integrate Mastermind Genomic Search Engine into GeneCards Suite and TGex
March 18, 2019
Genomenon Honored as One of the 2019 “Michigan 50 Companies to Watch”
February 28, 2019
Rare Genomics Institute Demonstrates the Power of Genomenon’s AI-Based Technology in Diagnosis
January 17, 2019
Emergence of Cancer Drug Resistance and Focus on Rare Diseases Found in 2018 Published Research
January 8, 2019
Genomenon Completes $2.5 Million Financing Round
November 27, 2018
Genomenon Publishes 3.7 Million Genomic Variants to Speed DNA Interpretation
October 29, 2018
GenomOncology and Genomenon Partner to Bring Genomic Literature Search to Molecular Tumor Board
October 18, 2018
Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation
October 16, 2018
Genomenon Partners with Rare Genomics Institute, Begins with Philanthropic Donation
September 24, 2018
Genomenon, Inc. Named TiE20 Award Winner at TiECon Detroit 2018
September 18, 2018
Genomenon Advances its Genomic Search Engine for Pharma and Diagnostic Labs with Supplemental Data
July 31, 2018
Genomenon Awarded Phase 2 NIH Grant to Apply Artificial Intelligence to Genomic Interpretation
June 26, 2018
The University of Vermont Health Network Standardizes on Genomenon’s Mastermind Genomic Search Engine
June 7, 2018
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Services
May 23, 2018
Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels
April 24, 2018
Genomenon’s Machine Learning Algorithm Identifies Key Biomarkers for Rare Genetic Disorders of Obesity
April 9, 2018
Genomenon Adds ACMG Classification Features to the Mastermind Genomic Search Engine
April 3, 2018
Genomenon Partners with Veritas Genetics to Create Next Generation Genomic Literature Prioritization Engine Powered By Machine Learning and AI
February 20, 2018
GenomeNext Embeds Mastermind Genomic Search Results in Olympus Platform for Scientific Literature Curation
February 6, 2018
Genomenon and Saphetor Announce Data Sharing Partnership
November 14, 2017
Genomenon Announces First Automated, Evidence-Based Blood Cancer Panel
October 18, 2017
LifeOmic Leverages Genomenon’s Mastermind Genomic Search Engine for Variant Interpretation
October 16, 2017
Genomenon Announces Free Mastermind Genomic Search Engine
August 8, 2017
Genomenon Announces the Next Advance in Genomic Interpretation
April 25, 2017
Genomenon Wins $1.8M NIH Grant to Automatically Curate Genomic Literature
March 21, 2017
Genomenon Delivers Evidence-Based Gene Panel Designs
February 13, 2017
Genomenon Accelerates Gene and Variant Curation With Launch Of Mastermind
November 10, 2016
Genomenon Completes $1.8 Million Extended Seed Financing Round
October 19, 2016
Genomenon Hires New CEO, Prepares to Launch First Product

Events

Meet the Genomenon team at one of the following industry events:

November 5, 2024

ASHG 2024 Annual Meeting

Denver, CO
The ASHG Conference is the world's largest human genetics and genomics meeting and exposition, providing a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. The Genomenon team will be on the show flloor at booth # 757. We’ll be posting more details soon on our scientific talks.
View event
November 19, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Vancouver, BC, Canada
The AMP Annual Meeting brings together professionals in molecular diagnostics and genomics to share knowledge, advances, and best practices in the field, with a focus on improving patient care and outcomes. The Genomenon and CKB team will be on the show floor at booth # 1233. We’ll be posting more details soon on our scientific talks.
View event
View all